Jagbir Gill1, James Dong, Michael Eng, David Landsberg, John S Gill. 1. 1 Division of Nephrology, University of British Columbia, Vancouver, Canada. 2 Center for Health Evaluation and Outcomes Sciences, Vancouver, Canada. 3 Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. 4 Tufts-New England Medical Center, Boston, MA. 5 Address correspondence to: Jagbir Gill, M.D., M.P.H., University of British Columbia, St. Paul's Hospital, Providence Building Ward 6a-1081 Burrard Street, Vancouver, BC, Canada V6Z 1YK.
Abstract
BACKGROUND: The role of pulsatile perfusion (PP) across different cold ischemic times (CIT) within different donor groups is unclear. This study examined the association of PP with delayed graft function (DGF) in all (n=94,709) deceased donor kidney transplants in the US between 2000 and 2011, as a function of CIT and donor type. METHODS: Using the Scientific Registry of Transplant Recipients data, all adult standard criteria donors (SCD, n=71,192), expanded criteria donors (ECD, n=15,122), and donors after circulatory death (DCD, n=8,395) kidney transplant recipients were identified. Within each donor group, transplants were stratified based on duration of CIT: 0 to 6 hours, 6.1 to 12 hours, 12.1 to 18 hours, 18.1 to 24 hours, 24.1 to 30 hours, 30.1 to 36 hours, and greater than 36 hours. Within each group, the odds of DGF with and without PP was determined after adjusting for donor, recipient, and transplant factors, including a propensity score for the likelihood of PP use, and clustering on transplant center using multivariable logistic regression. RESULTS: When stratified by donor type and CIT, the adjusted odds of DGF were lower with PP across all CIT in SCD transplants, when CIT was greater than 6 hours in ECD transplants, and when CIT was between 6 and 24 hours in DCD transplants. CIT was independently associated with a greater risk of DGF irrespective of storage method, but this effect was substantially modified by PP. CONCLUSION: PP is associated with a reduced risk of DGF irrespective of donor type and CIT. Although PP modifies the impact of CIT on the risk of DGF, it does not eliminate its association with DGF, suggesting the optimal strategy to reduce DGF is to minimize CIT and utilize PP in all deceased donor transplants.
BACKGROUND: The role of pulsatile perfusion (PP) across different cold ischemic times (CIT) within different donor groups is unclear. This study examined the association of PP with delayed graft function (DGF) in all (n=94,709) deceased donor kidney transplants in the US between 2000 and 2011, as a function of CIT and donor type. METHODS: Using the Scientific Registry of Transplant Recipients data, all adult standard criteria donors (SCD, n=71,192), expanded criteria donors (ECD, n=15,122), and donors after circulatory death (DCD, n=8,395) kidney transplant recipients were identified. Within each donor group, transplants were stratified based on duration of CIT: 0 to 6 hours, 6.1 to 12 hours, 12.1 to 18 hours, 18.1 to 24 hours, 24.1 to 30 hours, 30.1 to 36 hours, and greater than 36 hours. Within each group, the odds of DGF with and without PP was determined after adjusting for donor, recipient, and transplant factors, including a propensity score for the likelihood of PP use, and clustering on transplant center using multivariable logistic regression. RESULTS: When stratified by donor type and CIT, the adjusted odds of DGF were lower with PP across all CIT in SCD transplants, when CIT was greater than 6 hours in ECD transplants, and when CIT was between 6 and 24 hours in DCD transplants. CIT was independently associated with a greater risk of DGF irrespective of storage method, but this effect was substantially modified by PP. CONCLUSION: PP is associated with a reduced risk of DGF irrespective of donor type and CIT. Although PP modifies the impact of CIT on the risk of DGF, it does not eliminate its association with DGF, suggesting the optimal strategy to reduce DGF is to minimize CIT and utilize PP in all deceased donor transplants.
Authors: Dominic M Summers; Christopher J E Watson; Gavin J Pettigrew; Rachel J Johnson; David Collett; James M Neuberger; J Andrew Bradley Journal: Kidney Int Date: 2015-03-18 Impact factor: 10.612
Authors: María José Pérez-Sáez; Núria Montero; Dolores Redondo-Pachón; Marta Crespo; Julio Pascual Journal: Transplantation Date: 2017-04 Impact factor: 4.939
Authors: C R Parikh; I E Hall; R S Bhangoo; J Ficek; P L Abt; H Thiessen-Philbrook; H Lin; M Bimali; P T Murray; V Rao; B Schröppel; M D Doshi; F L Weng; P P Reese Journal: Am J Transplant Date: 2016-02-17 Impact factor: 8.086
Authors: J Moritz Kaths; Juan Echeverri; Yi Min Chun; Jun Yu Cen; Nicolas Goldaracena; Ivan Linares; Luke S Dingwell; Paul M Yip; Rohan John; Darius Bagli; Istvan Mucsi; Anand Ghanekar; David R Grant; Lisa A Robinson; Markus Selzner Journal: Transplantation Date: 2017-04 Impact factor: 4.939
Authors: Michael A J Moser; Steve Arcand; Han-Bin Lin; Chris Wojnarowicz; Jolanta Sawicka; Tamalina Banerjee; Yigang Luo; Gavin R Beck; Patrick P Luke; Grzegorz Sawicki Journal: PLoS One Date: 2016-06-21 Impact factor: 3.240